# Effect of a New HA Filler in Correcting Nasolabial Fold

> **NCT06574750** · NA · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 74 (actual)

## Conditions studied

- Aging Problems

## Interventions

- **DRUG:** CUREAⓇ (ARIBIO, Ltd., Seoul, Republic of Korea)
- **DRUG:** JuvedermⓇ (Q-Med AB, Uppsala, Sweden)

## Key facts

- **NCT ID:** NCT06574750
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-16
- **Primary completion:** 2023-05-08
- **Final completion:** 2023-05-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06574750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06574750, "Effect of a New HA Filler in Correcting Nasolabial Fold". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06574750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*